Sign Up Today and Learn More About WuXi NextCODE Stock
Invest in or calculate the value of your shares in WuXi NextCODE or other pre-IPO companies through EquityZen's platform.
WuXi NextCODE Stock
Using genomic information to improve health
About WuXi NextCODE Stock
Founded
2013
Headquarters
Cambridge, MA, US
Total Funding
455M
Industries
Software, Artificial Intelligence, Data and Analytics
WuXi NextCODE is a fully integrated contract genomics organization building the global standard platform for genomic data. With offices in Shanghai; Kendall Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we serve the leading population genomics, precision medicine, diagnostics and wellness initiatives and enterprises using the genome to improve health around the world. Our capabilities span study design, sequencing, secondary analysis, storage, and interpretation and scalable analytics – all backed by the most proven and widely used technology for organizing, mining and sharing genome sequence data. We are also applying the same capabilities to advance a growing range of sequence-based tests and scans in China. WuXi NextCODE is a WuXi Group company.
Investors in WuXi NextCODE
Discover investors in WuXi NextCODE stock and explore their portfolio companies
WuXi NextCODE Management
Leadership team at WuXi NextCODE
CEO
Hannes Thor Smárason
President and Chief Scientific Officer
Jeffrey Gulcher
Join now and verify your accreditation status to gain access to:
- WuXi NextCODE Current Valuation
- WuXi NextCODE Stock Price
- WuXi NextCODE Management
- Available deals in WuXi NextCODE and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- WuXi NextCODE Cap Table and Funding History by Share Class and Liquidity Preferences
- WuXi NextCODE Revenue and Financials
- WuXi NextCODE Highlights
- WuXi NextCODE Business Model
- WuXi NextCODE Risk Factors
- WuXi NextCODE Research Report from SACRA Research
Trading WuXi NextCODE Stock
How to invest in WuXi NextCODE stock?
Accredited investors can buy pre-IPO stock in companies like WuXi NextCODE through EquityZen funds. These investments are made available by existing WuXi NextCODE shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell WuXi NextCODE stock?
Shareholders can sell their WuXi NextCODE stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."